Search Results

There are 30163 results for: content related to: Atrial Fibrillation: Antithrombotic Therapy

  1. You have free access to this content
    Abstracts

    Journal of Thrombosis and Haemostasis

    Volume 3, Issue s1, August 2005, Pages: H01–SYM90,

    Version of Record online : 6 SEP 2013, DOI: 10.1111/j.1538-7836.2005.03000.x

  2. Dosing Options for Decreasing the Time to Achieve Therapeutic Anticoagulation When Reinitiating Warfarin: A Case Series

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 31, Issue 8, August 2011, Pages: 793–805, Ms. Karen T. Schultz and Dr. Tammy J. Bungard

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.31.8.793

  3. You have free access to this content
    Abstracts

    Journal of Thrombosis and Haemostasis

    Volume 13, Issue S2, June 2015, Pages: 1–997,

    Version of Record online : 3 JUN 2015, DOI: 10.1111/jth.12993

  4. You have free access to this content
    Posters

    Journal of Thrombosis and Haemostasis

    Volume 7, Issue s2, July 2009, Pages: 317–1168,

    Version of Record online : 15 JUN 2009, DOI: 10.1111/j.1538-7836.2009.03473_2.x

  5. You have free access to this content
    Abstracts

    Journal of Thrombosis and Haemostasis

    Volume 3, Issue s1, August 2005, Pages: P0001–P2386,

    Version of Record online : 9 SEP 2013, DOI: 10.1111/j.1538-7836.2005.0300c.x

  6. You have full text access to this OnlineOpen article
    Pharmacodynamics and pharmacokinetics during the transition from warfarin to rivaroxaban: a randomized study in healthy subjects

    British Journal of Clinical Pharmacology

    Volume 78, Issue 2, August 2014, Pages: 353–363, Dagmar Kubitza, Michael Becka, Wolfgang Mück and Jöern Krätzschmar

    Version of Record online : 21 JUL 2014, DOI: 10.1111/bcp.12349

  7. You have free access to this content
    Oral anticoagulation in nonvalvular atrial fibrillation

    Journal of Internal Medicine

    Volume 245, Issue 4, April 1999, Pages: 375–381, B. G. Koefoed and P. Petersen

    Version of Record online : 25 DEC 2001, DOI: 10.1046/j.1365-2796.1999.00461.x

  8. You have full text access to this OnlineOpen article
    Switching from rivaroxaban to warfarin: an open label pharmacodynamic study in healthy subjects

    British Journal of Clinical Pharmacology

    Volume 79, Issue 6, June 2015, Pages: 907–917, Kenneth Todd Moore, William Byra, Seema Vaidyanathan, Jaya Natarajan, Jay Ariyawansa, Hiba Salih and Kenneth C. Turner

    Version of Record online : 22 MAY 2015, DOI: 10.1111/bcp.12559

  9. You have free access to this content
    Antithrombotic therapy for stroke prevention in atrial fibrillation and mechanical heart valves

    American Journal of Hematology

    Volume 87, Issue S1, May 2012, Pages: S100–S107, John W. Eikelboom and Robert G. Hart

    Version of Record online : 3 MAR 2012, DOI: 10.1002/ajh.23136

  10. Preventing Recurrent Stroke and Other Serious Vascular Events

    Stroke: Practical Management, Third Edition

    C. Warlow, J. van Gijn, M. Dennis, J. Wardlaw, J. Bamford, G. Hankey, P. Sandercock, G. Rinkel, P. Langhorne, C. Sudlow, P. Rothwell, Pages: 789–901, 2008

    Published Online : 16 APR 2008, DOI: 10.1002/9780470696361.ch16

  11. You have free access to this content
    Abstract

    Journal of Thrombosis and Haemostasis

    Volume 1, Issue S1, July 2003, Pages: P1919–P1999a,

    Version of Record online : 7 MAR 2014, DOI: 10.1111/j.1538-7836.2003.tb00131.x

  12. A Regulatory Science Perspective on Warfarin Therapy: A Pharmacogenetic Opportunity

    The Journal of Clinical Pharmacology

    Volume 49, Issue 2, February 2009, Pages: 138–146, Myong-Jin Kim, Shiew-Mei Huang, Urs A. Meyer, Atiqur Rahman and Lawrence J. Lesko

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270008328098

  13. Retrospective Evaluation of a Possible Interaction Between Warfarin and Levofloxacin

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 25, Issue 1, January 2005, Pages: 67–73, Kenneth L. McCall, John C. Scott and H. Glenn Anderson Jr.

    Version of Record online : 16 JAN 2012, DOI: 10.1592/phco.25.1.67.55624

  14. Management of Atrial Fibrillation: Direct Factor IIa and Xa Inhibitors or “Warfarin Shotgun”?

    Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine

    Volume 79, Issue 6, November/December 2012, Pages: 705–720, Jonathan L. Halperin and Richert E. Goyette

    Version of Record online : 13 DEC 2012, DOI: 10.1002/msj.21346

  15. Pharmacology of Vitamin K Antagonists

    Inpatient Anticoagulation

    Jaekyu Shin, Steven R. Kayser, Pages: 25–46, 2011

    Published Online : 3 OCT 2011, DOI: 10.1002/9781118067178.ch2

  16. You have free access to this content
    The decision to anticoagulate: Assessing whether benefits outweigh the risks for patients with atrial fibrillation

    Clinical Cardiology

    Volume 27, Issue 6, June 2004, Pages: 313–320, Geno Merli and Howard H. Weitz

    Version of Record online : 5 DEC 2006, DOI: 10.1002/clc.4960270603

  17. Determination of the Lack of a Drug Interaction Between Azithromycin and Warfarin

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 24, Issue 2, February 2004, Pages: 188–194, Kenneth L. McCall and and Angela D. Jones

    Version of Record online : 16 JAN 2012, DOI: 10.1592/phco.24.2.188.33148

  18. You have free access to this content
    Long-term low-dose warfarin use is effective in the prevention of recurrent venous thromboembolism: yes

    Journal of Thrombosis and Haemostasis

    Volume 2, Issue 7, July 2004, Pages: 1034–1037, P. M. Ridker

    Version of Record online : 23 JUN 2004, DOI: 10.1111/j.1538-7836.2004.00813.x

  19. Venous Thromboembolic Disease

    Management Strategies in Antithrombotic Therapy

    Arman T. Askari, Adrian W. Messerli, A. Michael Lincoff, Pages: 283–316, 2007

    Published Online : 6 NOV 2007, DOI: 10.1002/9780470518137.ch12

  20. Potentiation of anticoagulant effect of warfarin caused by enantioselective metabolic inhibition by the uricosuric agent benzbromarone

    Clinical Pharmacology & Therapeutics

    Volume 66, Issue 6, December 1999, Pages: 569–581, Harumi Takahashi, Teruki Sato, Yoshiaki Shimoyama, Noriko Shioda, Teppei Shimizu, Suzuko Kubo, Noboru Tamura, Hitoshi Tainaka, Toshio Yasumori and Hirotoshi Echizen

    Version of Record online : 19 DEC 1999, DOI: 10.1053/cp.1999.v66.103378001